Evidence map›Paper›PMID 22687512›Full record

ArticleAntimicrobial agents and chemotherapy2012

Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.

Rodrigo E Mendes, Lalitagauri M Deshpande, Andrew J Costello, David J Farrell

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Molecular basis of linezolid resistance inAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Molecular epidemiology and characterization of antimicrobial-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  12. Molecular Detection and Characterization of theBioMed research international · 2023
    Article
  13. Article
  14. Linezolid-ResistantFoods (Basel, Switzerland) · 2022
    Article
  15. The Dissemination of Fusidic Acid Resistance AmongInfection and drug resistance · 2022
    Article
  16. Role of Efflux in Antibiotic Resistance ofFrontiers in microbiology · 2022
    Article
  17. Article
  18. Article
  19. Spread of Linezolid-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
  20. High-Resolution Typing ofJournal of clinical microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rodrigo E MendesJMI Laboratories, North Liberty, Iowa, USA. rodrigo-mendes@jmilabs.com
Lalitagauri M Deshpande
Andrew J Costello
David J Farrell
JMI Laboratories · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiology of Staphylococcus epidermidis in U.S. hospitals remains limited. This study aimed to address the genetic backgrounds of linezolid-susceptible and -resistant S. epidermidis strains (isolated in 2010), including cfr-carrying strains. In addition, the antimicrobial susceptibility profiles and linezolid resistance mechanisms among clonal lineages were assessed. A total of 71 S. epidermidis isolates were selected, and linezolid-resistant strains were screened for cfr and mutations in 23S rRNA, L3, and L4. All isolates were subjected to multilocus sequence typing (MLST), and the results were analyzed by eBURST. Overall, 27 sequence types (STs) were detected, and ST5 (21.1%) and ST2 (16.9%) predominated. The majority (62/71; 87.3%) of STs belonged to clonal complex 2 (CC2), which was mostly comprised of subclusters CC2-II (41/62; 66.1%) and CC2-I (21/62; 33.9%). Other STs were grouped within CC23 or CC32 or were singletons. CC2-I strains were more likely to display a methicillin (95.2% versus 33.3 to 70.7%), a linezolid (47.6% versus 0.0 to 7.3%), or a multidrug (81.0% versus 33.3 to 36.6%) resistance phenotype. Among linezolid-resistant isolates, cfr was noted only within CC2 strains, and it was detected equally in the CC2-I (3/10; 30.0%) and CC2-II (1/3; 33.3%) subclusters. 23S rRNA mutations (G2576 [seven strains] and C2534 [one strain]) were observed only among CC2-I (8/10; 80.0%) isolates. Strains showing a G2576 alteration also had M156 (7/7; 100.0%) and/or H146 (6/7; 85.7%) L3 modifications. This study provides an overview of the S. epidermidis clonal distribution and reports higher resistance rates among CC2-I strains. The results show that cfr may be acquired and expressed by both CC2 main subclusters, while 23S rRNA mutations appeared more often within CC2-I strains. Interestingly, these 23S rRNA mutants also had L3 alterations, which may act synergistically or in a compensatory manner to minimize the fitness cost while providing survival advantages under selective pressure.

Indexed as

AcetamidesAdultAgedAged, 80 and overAnti-Bacterial AgentsBacterial ProteinsBacterial Typing TechniquesChild, PreschoolDrug Resistance, Multiple, BacterialFemaleHospitalsHumansInfantLinezolidMaleMiddle AgedAcetamidesAnti-Bacterial AgentsBacterial ProteinsLinezolidOxazolidinonesRNA, Ribosomal, 23S

Identifiers

PMID22687512
PMCPMC3421855
OpenAlexW2048824738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.